Simultaneous Quantitative Analysis of Six Proton-Pump Inhibitors with a Single Marker and Evaluation of Stability of Investigated Drugs in Polypropylene Syringes for Continuous Infusion Use

References

• LassalleM, Le TriT, BardouM, et al. Use of proton pump inhibitors in adults in France: a nationwide drug utilization study. Eur J Clin Pharmacol. 2020;76(3):449–457. doi:10.1007/s00228-019-02810-1.31838548
   PubMed Web of Science ®Google Scholar
• ScarpignatoC, GattaL, ZulloA, et al. Effective and safe proton pump inhibitor therapy in acid-related diseases-a position paper addressing benefits and potential harms of acid suppression. BMC Med. 2016;14(1):179. doi:10.1186/s12916-016-0718-z.27825371
   PubMed Web of Science ®Google Scholar
• KheradO, RestelliniS, MartelM, et al. Proton pump inhibitors for upper gastrointestinal bleeding. Best Pract Res Clin Gastroenterology. 2019;42–43:101609. doi:10.1016/j.bpg.2019.04.002.
   PubMed Web of Science ®Google Scholar
• WordenJC, HannaKS. Optimizing proton pump inhibitor therapy for treatment of nonvariceal upper gastrointestinal bleeding. Am J Health Sys Pharm. 2017;74(3):109–116. doi:10.2146/ajhp151032.
   PubMed Web of Science ®Google Scholar
• SacharH, VaidyaK, LaineL. Intermittent vs continuous proton pump inhibitor therapy for high-risk bleeding ulcers: a systematic review and meta-analysis. JAMA Intern Med. 2014;174(11):1755–1762. doi:10.1001/jamainternmed.2014.405625201154
   PubMed Web of Science ®Google Scholar
• LuoH, FanQ, BianT, et al. Awareness, attitude and behavior regarding proton pump inhibitor among medical staff in the southwest of China. BMC Health Services Res. 2019;19(1):880. doi:10.1186/s12913-019-4725-6.
   PubMed Web of Science ®Google Scholar
• Schnoll-SussmanF, NiecR, KatzPO. Proton pump inhibitors: the good, bad, and ugly. Gastrointestinal Endoscopy Clin North Am. 2020;30(2):239–251. doi:10.1016/j.giec.2019.12.005
   PubMedGoogle Scholar
• OthmanF, CardTR, CrooksCJ. Proton pump inhibitor prescribing patterns in the UK: a primary care database study. Pharmacoepidemiol Drug Saf. 2016;25(9):1079–1087. doi:10.1002/pds.4043.27255671
   PubMed Web of Science ®Google Scholar
• WangB-Y, ZhangJ, WangJ-L, et al. Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer. J Exp Clin Cancer Res. 2015;34(1):85. doi:10.1186/s13046-015-0194-x.26297142
   PubMed Web of Science ®Google Scholar
• JungSW, KimSY, ChoeJW, et al. Standard and double-dose intravenous proton pump inhibitor injections for prevention of bleeding after endoscopic resection.J Gastroenterology Hepatology. 2017;32(4):778–781. doi:10.1111/jgh.13597.
   PubMed Web of Science ®Google Scholar
• BharathiDV, HothaKK, JagadeeshB, et al. Simultaneous estimation of four proton pump inhibitors-lansoprazole, omeprazole, pantoprazole and rabeprazole: development of a novel generic HPLC-UV method and its application to clinical pharmacokinetic study. Biomed Chromatography. 2009;23(7):732–739. doi:10.1002/bmc.1177.
   PubMed Web of Science ®Google Scholar
• NoubaraniM, KeyhanfarF, MotevalianM, et al. Improved HPLC method for determination of four PPIs, omeprazole, pantoprazole, lansoprazole and rabeprazole in human plasma. J Pharm Pharm Sci. 2010;13(1):1–10. doi:10.18433/J3GP4Q20456825
   PubMed Web of Science ®Google Scholar
• PoloniniHC, SilvaSL, LouresS, et al. Compatibility of proton pump inhibitors in a preservative-free suspending vehicle. Eur J Hospital Pharm. 2018;25(3):150–156. doi:10.1136/ejhpharm-2016-001034
   PubMedGoogle Scholar
• El-SherifZA, MohamedAO, El-BardicyMG, et al. Reversed-phase high performance liquid chromatographic method for the determination of lansoprazole, omeprazole and pantoprazole sodium sesquihydrate in presence of their acid-induced degradation products. Chem Pharm Bull (Tokyo). 2006;54(6):814–818. doi:10.1248/cpb.54.81416755049
   PubMed Web of Science ®Google Scholar
• AshourS, OmarS. A modified high-performance liquid chromatographic method for the analysis of pantoprazole sodium in pharmaceutical dosage forms using lansoprazole as internal standard. Arabian J Chem. 2016;9(Supply 1):S114–S119. doi:10.1016/j.arabjc.2011.02.010
   Web of Science ®Google Scholar
• EkpeA, JacobsenT. Effect of various salts on the stability of lansoprazole, omeprazole, and pantoprazole as determined by high-performance liquid chromatography. Drug Dev Indus Pharm. 1999;25(9):1057–1065. doi:10.1081/ddc-100102270.
   PubMed Web of Science ®Google Scholar
• ZhaoP, DengM, HuangP, et al. Solid-phase extraction combined with dispersive liquid-liquid microextraction and chiral liquid chromatography-tandem mass spectrometry for the simultaneous enantioselective determination of representative proton-pump inhibitors in water samples. Anal Bio Anal Chem. 2016;408(23):6281–6292. doi:10.1007/s00216-016-9753-z.
   Web of Science ®Google Scholar
• PerumalSS, EkambaramSP, RajaS. Analytical method development and validation of simultaneous estimation of rabeprazole, pantoprazole, and itopride by reverse-phase high-performance liquid chromatography. J Food Drug Anal. 2014;22(4):520–526. doi:10.1016/j.jfda.2014.05.003.28911469
   PubMed Web of Science ®Google Scholar
• PatelBH, SuhagiaBN, PatelMM, et al. Determination of pantoprazole, rabeprazole, esomeprazole, domperidone and itopride in pharmaceutical products by reversed phase liquid chromatography using single mobile phase. Chromatographia. 2007;65(11–12):743–748.
   Web of Science ®Google Scholar
• RajabA, ToumaM, RudlerH, et al. Slow, spontaneous degradation of lansoprazole, omeprazole and pantoprazole tablets: isolation and structural characterization of the toxic antioxidants 3H-benzimidazole-2-thiones. Die Pharmazie. 2013;68(9):749–754.24147343
   PubMed Web of Science ®Google Scholar
• ChennuruLN, ChoppariT, DuvvuriS, et al. Enantiomeric separation of proton pump inhibitors on new generation chiral columns using LC and supercritical fluid chromatography. J Sep Sci. 2013;36(18):3004–3010. doi:10.1002/jssc.20130041923857714
   PubMed Web of Science ®Google Scholar
• HishinumaT, SuzukiK, YamaguchiH, et al. Simple quantification of lansoprazole and rabeprazole concentrations in human serum by liquid chromatography/tandem mass spectrometry. J Chromatography B. 2008;870(1):38–45. doi:10.1016/j.jchromb.2008.05.034.
   PubMed Web of Science ®Google Scholar
• ZhangY, ChenX, GuQ, et al. Quantification of rabeprazole in human plasma by liquid chromatography-tandem mass spectrometry. Anal Chim Acta. 2004;523:171–175.
   Web of Science ®Google Scholar
• AddoRT, DavisK, UbaleR, et al. Development and validation of a UPLC method for rapid and simultaneous analysis of proton pump inhibitors. AAPS PharmSciTech. 2015;16(1):30–34. doi:10.1208/s12249-014-0207-725160675
   PubMed Web of Science ®Google Scholar
• VaithiyanathanSJ, RajappanM, KannappanV. Stability-indicating HPLC method for the simultaneous determination of pantoprazole, rabeprazole, lansoprazole and domperidone from their combination dosage forms. Int J Drug Dev Res. 2011;3(4):323–335.
   Google Scholar
• El-KommosME, KhashabaPY, AliHRH, et al. Different chromatographic and electrophoretic methods for analysis of proton pump inhibitors (PPIs): a review. J Liquid Chromatography Related Tech. 2015;38(18):1639–1659. doi:10.1080/10826076.2015.1079722
   Web of Science ®Google Scholar
• GhadgeMR, TambeVS, DaradePG. Analysis of proton pump inhibitors in bulk and in different dosage forms -a review. Int J Pharma Res Rev. 2014;3(1):45–57.
   Google Scholar
• YiH, ZhouJ, ShangXY, et al. Multi-component analysis of ilex kudingcha c. j. tseng by a single marker quantification method and chemometric discrimination of HPLC fingerprints. Molecules. 2018;23(4):854. doi:10.3390/molecules23040854
   PubMed Web of Science ®Google Scholar
• LiY, ZhangY, ZhangZ, et al. Quality evaluation of gastrodia elata tubers based on HPLC fingerprint analyses and quantitative analysis of multi-components by single marker. Molecules. 2019;24(8):1521. doi:10.3390/molecules24081521.
   PubMed Web of Science ®Google Scholar
• ZhuC, LiX, ZhangB, et al. Quantitative analysis of multi-components by single marker—a rational method for the internal quality of Chinese herbal medicine. Integrative Med Res. 2017;6(1):1–11. doi:10.1016/j.imr.2017.01.008
   PubMed Web of Science ®Google Scholar
• ChenLH, WuY, GuanYM, et al. Analysis of the high-performance liquid chromatography fingerprints and quantitative analysis of multicomponents by single marker of products of fermented cordyceps sinensis. J Anal Methods Chem. 2018;59(43):914. doi:10.1155/2018/5943914.
   Web of Science ®Google Scholar
• WangS, XuY, WangY, et al. Simultaneous determination of six active components in oviductus ranae via quantitative analysis of multicomponents by single marker. J Anal Methods Chem. 2017;91(9):48. doi:10.1155/2017/9194847
   Web of Science ®Google Scholar
• WangC-Q, JiaX-H, ZhuS, et al. A systematic study on the influencing parameters and improvement of quantitative analysis of multi-component with single marker method using notoginseng as research subject. Talanta. 2015;134:587–595. doi:10.1016/j.talanta.2014.11.028.25618711
   PubMed Web of Science ®Google Scholar
• ChenA, SunL, YuanH, et al. A holistic strategy for quality and safety control of traditional Chinese medicines by the “iVarious” standard system. J Pharm Anal. 2017;7(5):271–279. doi:10.1016/j.jpha.2017.07.008.29404049
   PubMed Web of Science ®Google Scholar
• KristlA. Acido-basic properties of proton pump inhibitors in aqueous solutions. Drug Dev Ind Pharm. 2009;35(1):114–117. doi:10.1080/03639040802220284.18720145
   PubMed Web of Science ®Google Scholar
• GuptaHP, SainiK, DhingraP, et al. Study of acid catalyzed reactions of proton pump inhibitors at D.M.E. Portugaliae Electrochimica Acta. 2007;26(5):433–448. doi:10.4152/pea.200805433.
   Google Scholar